CTRE:NYE-CareTrust REIT Inc. (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 30.76

Change

0.00 (0.00)%

Market Cap

USD 4.74B

Volume

1.19M

Analyst Target

USD 18.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

CareTrust REIT, Inc.'s ("CareTrust REIT" or the "Company") primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of March 31, 2024, the Company owned directly or through a joint venture and leased to independent operators, 228 skilled nursing facilities ("SNFs"), multi-service campuses, assisted living facilities ("ALFs") and independent living facilities ("ILFs") consisting of 24,189 operational beds and units located in 29 states with the highest concentration of properties by rental income located in California and Texas. As of March 31, 2024, the Company also had other real estate related investments consisting of one preferred equity investment, nine real estate secured loans receivable and four mezzanine loans receivable with a carrying value of $233.3 million.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

N/A

USD 76.31B
VTR Ventas Inc

N/A

USD 26.47B
DOC Healthpeak Properties Inc

N/A

USD 15.80B
AHR American Healthcare REIT, Inc.

N/A

USD 3.99B
NHI National Health Investors Inc

N/A

USD 3.65B
LTC LTC Properties Inc

N/A

USD 1.60B
UHT Universal Health Realty Income..

N/A

USD 0.63B
CHCT Community Healthcare Trust Inc

N/A

USD 0.47B
GMRE-PA Global Medical REIT Inc

N/A

USD 0.41B
OHI Omega Healthcare Investors Inc

N/A

N/A

ETFs Containing CTRE

FXU First Trust Utilities Alp.. 4.41 % 0.63 %

N/A

N/A
HDLV 3.31 % 0.00 %

N/A

N/A
XLUY 3.00 % 0.00 %

N/A

N/A
CZA Invesco Zacks Mid-Cap ETF 1.84 % 0.65 %

N/A

N/A
HSMV First Trust Horizon Manag.. 1.59 % 0.00 %

N/A

USD 0.02B
PSCF Invesco S&P SmallCap Fina.. 1.34 % 0.29 %

N/A

USD 0.02B
XSLV Invesco S&P SmallCap Low .. 1.14 % 0.25 %

N/A

USD 0.33B
DIVA 1.07 % 1.00 %

N/A

N/A
ULOV:LSE 0.72 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 37.44% 71% C- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.44% 71% C- 88% B+
Trailing 12 Months  
Capital Gain 50.05% 64% D 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.05% 64% D 87% B+
Trailing 5 Years  
Capital Gain 30.87% 92% A 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.87% 92% A 65% D
Average Annual (5 Year Horizon)  
Capital Gain 8.02% N/A N/A 64% D
Dividend Return 13.33% N/A N/A 70% C-
Total Return 5.31% N/A N/A 82% B
Risk Return Profile  
Volatility (Standard Deviation) 22.59% N/A N/A 46% F
Risk Adjusted Return 59.02% N/A N/A 75% C
Market Capitalization 4.74B 70% C- 77% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.